InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,555.74
(
-0.16%
)
US TECH 100
19,095.20
(
-1.09%
)
Dow Jones
40,358.09
(
-0.14%
)
Brent Oil
80.49
(
-0.35%
)
Bitcoin
65,951.62
(
0.04%
)
Post# of 252658
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: JJM760 post# 164098

Tuesday, 07/16/2013 12:08:56 PM

Tuesday, July 16, 2013 12:08:56 PM

Post# of 252658
>>Bosulif

It's a new drug and it's made by Pfizer and so the docs might have been detailed on it. Iclusig is not yet even approved in Europe, where some of the Bosulif support came from.

Most community oncologists might only see a few CML patients in a year. So no reason to be surprised that they may be fairly clueless about the latest developments.

Iclusig scripts are tracking well above the Bosulif trajectory in the US despite a later start, so some docs are clearly clued-in.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up